Search Results - "ZHENGSHENG YAO"
-
1
Interleukin-15 combined with an anti-CD40 antibody provides enhanced therapeutic efficacy for murine models of colon cancer
Published in Proceedings of the National Academy of Sciences - PNAS (05-05-2009)“…IL-15 has potential as an immunotherapeutic agent for cancer treatment because it is a critical factor for the proliferation and activation of natural killer…”
Get full text
Journal Article -
2
Combined-modality radioimmunotherapy : synergistic effect of paclitaxel and additive effect of bevacizumab
Published in Nuclear medicine and biology (01-05-2012)“…Abstract Introduction This study was undertaken to investigate the effect of paclitaxel and bevacizumab on the therapeutic efficacy of90 Y-labeled B3…”
Get full text
Journal Article -
3
Pretargeting radioimmunotherapy of a murine model of adult T-cell leukemia with the α-emitting radionuclide, bismuth 213
Published in Blood (01-07-2002)“…We used a pretargeting technique to treat a nonobese diabetic/severe combined immunodeficient murine model of human adult T-cell leukemia with an anti-Tac…”
Get full text
Journal Article -
4
Effective therapy for a murine model of human anaplastic large-cell lymphoma with the anti-CD30 monoclonal antibody, HeFi-1, does not require activating Fc receptors
Published in Blood (15-07-2006)“…CD30 is a member of the tumor necrosis factor receptor family. Overexpression of CD30 on some neoplasms versus its limited expression on normal tissues makes…”
Get full text
Journal Article -
5
Effective Therapy of Murine Models of Human Leukemia and Lymphoma with Radiolabeled Anti-CD30 Antibody, HeFi-1
Published in Proceedings of the National Academy of Sciences - PNAS (15-05-2007)“…CD30 is a member of the TNF receptor superfamily. Overexpression of CD30 on some neoplasms versus limited expression on normal tissues makes this receptor a…”
Get full text
Journal Article -
6
Effect of albumin fusion on the biodistribution of interleukin-2
Published in Cancer Immunology, Immunotherapy (01-05-2004)“…We investigated and compared the biodistribution of Albuleukin, a human serum albumin (HSA)-interleukin-2 (IL-2) fusion protein, with those of IL-2 and HSA…”
Get full text
Journal Article -
7
Effect of chelator conjugation level and injection dose on tumor and organ uptake of 111In-labeled MORAb-009, an anti-mesothelin antibody
Published in Nuclear medicine and biology (01-11-2011)“…Radiolabeling of a monoclonal antibody (mAb) with a metallic radionuclide requires the conjugation of a bifunctional chelator to the mAb. The conjugation,…”
Get full text
Journal Article -
8
Effect of Molecular Size of Pegylated Peptide on the Pharmacokinetics and Tumor Targeting in Lymphoma-Bearing Mice
Published in Clinical cancer research (01-09-2003)“…Purpose: Rapid blood and body clearances have hampered effective tumor targeting by small molecules. We used branched poly(ethylene glycol) (pegylated)…”
Get full text
Journal Article -
9
Comparative Cellular Catabolism and Retention of Astatine-, Bismuth-, and Lead-Radiolabeled Internalizing Monoclonal Antibody
Published in The Journal of nuclear medicine (1978) (01-10-2001)“…Monoclonal antibodies (mAbs) labeled with alpha-emitting radionuclides such as (211)At, (212)Bi, (213)Bi, and (212)Pb (which decays by beta-emission to its…”
Get full text
Journal Article -
10
The anti-CD25 monoclonal antibody 7G7/B6, armed with the α-emitter 211At, provides effective radioimmunotherapy for a murine model of leukemia
Published in Cancer research (Chicago, Ill.) (15-08-2006)“…Radioimmunotherapy of cancer with radiolabeled antibodies has shown promise. alpha-Particles are very attractive for cancer therapy, especially for isolated…”
Get full text
Journal Article -
11
IL-15 enhanced antibody-dependent cellular cytotoxicity mediated by NK cells and macrophages
Published in Proceedings of the National Academy of Sciences - PNAS (13-11-2018)“…The goal of cancer immunotherapy is to stimulate the host immune system to attack malignant cells. Antibody-dependent cellular cytotoxicity (ADCC) is a pivotal…”
Get full text
Journal Article -
12
The Relationship of Glycosylation and Isoelectric Point with Tumor Accumulation of Avidin
Published in The Journal of nuclear medicine (1978) (01-03-1999)“…Radiolabeled avidin markedly accumulated in intraperitoneal tumors and was cleared rapidly from circulation when given intraperitoneally. This study…”
Get full text
Journal Article -
13
Pretargeted α Emitting Radioimmunotherapy Using 213Bi 1,4,7,10-Tetraazacyclododecane-N,N′,N″,N‴-Tetraacetic Acid-Biotin
Published in Clinical cancer research (01-05-2004)“…Purpose: The use of an α emitter for radioimmunotherapy has potential advantages compared with β emitters. When administered systemically optimal targeting of…”
Get full text
Journal Article -
14
Intratumoral Distribution of Radiolabeled Antibody and Radioimmunotherapy in Experimental Liver Metastases Model of Nude Mouse
Published in The Journal of nuclear medicine (1978) (01-04-1999)“…The biodistribution and intratumoral distribution of radiolabeled anticarcinoembryonic antigen (CEA) monoclonal antibody in experimental liver metastases and…”
Get full text
Journal Article -
15
Tumor targeting properties of two monoclonal antibodies directed against two different antigens, shed and non-shed, expressed on the same tumor
Published in The Journal of nuclear medicine (1978) (01-05-2017)“…Objectives: To investigate key parameters to improve the tumor delivery and penetration. We performed biodistribution (BD), PET imaging and autoradiography…”
Get full text
Journal Article -
16
Improved renal clearance and tumor targeting of 99mTc-labeled anti-Tac monoclonal antibody Fab by chemical modifications
Published in Nuclear medicine and biology (01-02-2002)“…This study was undertaken to improve the renal clearance and tumor targeting properties of 99mTc-labeled humanized anti-Tac (HuTac) monoclonal antibody Fab…”
Get full text
Journal Article -
17
Augmented IL-15Rα expression by CD40 activation is critical in synergistic CD8 T cell-mediated antitumor activity of anti-CD40 antibody with IL-15 in TRAMP-C2 tumors in mice
Published in The Journal of immunology (1950) (15-06-2012)“…IL-15 has potential as an immunotherapeutic agent for cancer treatment because it is a critical factor for the proliferation and activation of NK and CD8(+) T…”
Get full text
Journal Article -
18
Tumor-Shed Antigen Affects Antibody Tumor Targeting: Comparison of Two 89 Zr-Labeled Antibodies Directed against Shed or Nonshed Antigens
Published in Contrast media and molecular imaging (2018)“…We investigated the effect of shed antigen mesothelin on the tumor uptake of amatuximab, a therapeutic anti-mesothelin mAb clinically tested in mesothelioma…”
Get full text
Journal Article -
19
Tumor and organ uptake of (64)Cu-labeled MORAb-009 (amatuximab), an anti-mesothelin antibody, by PET imaging and biodistribution studies
Published in Nuclear medicine and biology (01-11-2015)“…To investigate the effect of the injection dose of MORAb-009 (amatuximab, an anti-mesothelin monoclonal antibody), the tumor size and the level of shed…”
Get full text
Journal Article -
20
Anti‐murine Antibody Response to Mouse Monoclonal Antibodies in Cancer Patients
Published in Japanese Journal of Cancer Research (01-09-1997)“…Although development of human anti‐murine inununoglobulin antibody (HAMA) is often seen in patients receiving murine antibodies, the variety of methods used…”
Get full text
Journal Article